Brief: Nuvectis Pharma Inc Reports First Quarter 2023 Financial Results
10/05/2023 13:51
May 10 (Reuters) - Nuvectis Pharma Inc NVCT.O :
* NUVECTIS PHARMA, INC. REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS AND BUSINESS HIGHLIGHTS
* CASH, CASH EQUIVALENTS, AND SHORT-TERM INVESTMENTS WERE
$15.5
MILLION AS OF MARCH 31, 2023
* QTRLY NET LOSS PER COMMON SHARE $0.27
* Q1 EARNINGS PER SHARE VIEW $-0.44 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX1mVVs8
Further company coverage: NVCT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nuvectis Pharma
See all newsNuvectis Pharma Inc reports results for the quarter ended June 30 - Earnings Summary
Nuvectis Pharma Inc expected to post a loss of 26 cents a share - Earnings Preview
Brief: Ciprocopan (NXP100) Receives Marketing Approval In China For The Treatment Of Patients With PNH Previously Untreated With Complement Inhibitors
U.S. STOCKS ON THE MOVE-Chip stocks, Unicycive, Roblox
U.S. STOCKS ON THE MOVE-AMD, Roblox, Olin